Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ATHE Relative to the S&P 500

ATHE Relative to the Sector

Seasonal Chart Analysis

Analysis of the Alterity Therapeutics Limited (NASD:ATHE) seasonal charts above shows that a Buy Date of May 22 and a Sell Date of August 10 has resulted in a geometric average return of 9.34% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 13 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 33.28% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer’s, Huntington, Parkinson s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

To download ATHE seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ATHE